These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7547152)

  • 1. ACE inhibitors after myocardial infarction.
    Jackson G
    Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors in acute myocardial infarction.
    Sethi KK; Mehrotra R
    Indian Heart J; 1994; 46(4):131-7. PubMed ID: 7875698
    [No Abstract]   [Full Text] [Related]  

  • 4. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ
    Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive therapy with ACE inhibitors for coronary patients].
    Keltai M
    Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct].
    Buksa M
    Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
    Kjøller-Hansen L; Steffensen R; Grande P
    Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan, captopril, or both in myocardial infarction.
    McAnulty JH
    N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14985495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
    Danchin N
    Herz; 2002 Dec; 27(8):(18). PubMed ID: 12608391
    [No Abstract]   [Full Text] [Related]  

  • 15. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS; Gassler JP
    Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
    [No Abstract]   [Full Text] [Related]  

  • 16. ACE inhibitors in the management and prevention of heart failure.
    O'Callaghan PA; Walsh MJ
    Ir Med J; 1995; 88(2):48,50. PubMed ID: 7775143
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
    Kardiologiia; 2008; 48(11):64-8. PubMed ID: 19076083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
    Reynolds G; Hall AS; Ball SG
    Eur J Clin Pharmacol; 1996; 49 Suppl 1():S35-9. PubMed ID: 8834930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.